<DOC>
	<DOCNO>NCT00450684</DOCNO>
	<brief_summary>The objective multicentre prospective therapeutic study evaluate effect CRT right leave ventricular function patient CHD medium long term . Patients reject randomization pace right ventricular pace alone enrol group C continuous biventricular pacing , main group study . Optional : Immediately implantation patient divide group A B ( randomize , single blind ( patient ) , cross-over design ) . The treatment complete follow-up examination take approximately 18 month include seven visit - one previous CRT six certain time afterward . At selected time interval echocardiographic 3D Tissue Doppler Imaging evaluate global regional ventricular function perform . Subjective quality life assessment ( questionnaire ) also perform define follow-up interval , applicable ( optional ) also objective assessment physical performance ( VO2 max ) . 55 patient also include child adults CHD plan include study . The main target provide evidence effectiveness CRT biventricular stimulation term improve ventricular function ( ejection fraction QRS interval ) .</brief_summary>
	<brief_title>Cardiac Resynchronization Therapy Congenital Heart Defects</brief_title>
	<detailed_description />
	<mesh_term>Heart Defects , Congenital</mesh_term>
	<criteria>Patients congenital heart defect Heart failure Morphologically right left system ventricle absolute ejection fraction &lt; 40 % fail ventricle NYHA class IIIV Optimal drug therapy heart failure accord ESC guideline QRS interval â‰¥ 120 m ( demonstrate least two relevant ECG derivation , depend exist bundle branch block symptom ) Patients chronic stimulation subpulmonary ventricle 1 2ventricle pacemaker , also meet abovementioned criterion Patients morphologically right ventricle system position significant insufficiency systemic atrioventricular valve , also meet criterion list PTCA , cardiomyoplasty myocardial infarction / unstable angina pectoris cerebral insult within 6 week precede planned cardiac resynchronisation therapy Patients pulmonary hypertension / Eisenmenger 's syndrome Life expectancy &lt; 1 year due noncardiac disease Anticipated poor compliance patient Pregnancy breastfeed Known persistent abuse prescription medicine , recreational drug alcohol</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>